Figure 1From: Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel IHC presenting TP and TUBB3 expressions (magnification, ×400). A, TP negative; B, TP positive; C, TUBB3 negative; D, TUBB3 positive.Back to article page